Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 20 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.21
EARNINGS PER SHARE (EPS) AVG 3Y
-0.25
EARNINGS PER SHARE (EPS) AVG 5Y
-0.25
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$11.24M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$11.24M
Earnings Per Share (EPS)
-16.53
TTM Avg
-14.84
3Y Avg
-116.30
5Y Avg
-277.16
Market Cap
$11.14M
Earnings Per Share (EPS)
-0.60
TTM Avg
-2.13
3Y Avg
-4.47
5Y Avg
-13.49
Market Cap
$11.30M
Earnings Per Share (EPS)
-2.50
TTM Avg
-0.85
3Y Avg
-11.13
5Y Avg
-30.50
Market Cap
$11.20M
Earnings Per Share (EPS)
-3.20
TTM Avg
-7.58
3Y Avg
-60.73
5Y Avg
-69.78
Market Cap
$10.93M
Earnings Per Share (EPS)
-1.64
TTM Avg
-2.15
3Y Avg
-4.34
5Y Avg
-5.45
Market Cap
$10.81M
Earnings Per Share (EPS)
-4.43
TTM Avg
-27.97
3Y Avg
-98701.49
5Y Avg
-256134.32
Market Cap
$11.66M
Earnings Per Share (EPS)
-0.47
TTM Avg
-0.74
3Y Avg
-0.71
5Y Avg
-0.50
Market Cap
$12.06M
Earnings Per Share (EPS)
-1.62
TTM Avg
-966.25
3Y Avg
-483.82
5Y Avg
-322.89
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $11.24M | N/A | -0.21 | -0.25 | -0.25 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.24M | -16.53 | -14.84 | -116.30 | -277.16 |
| Biofrontera Inc. (BFRI)vs › | $11.14M | -0.60 | -2.13 | -4.47 | -13.49 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -2.50 | -0.85 | -11.13 | -30.50 |
| BioVie Inc. (BIVI)vs › | $11.20M | -3.20 | -7.58 | -60.73 | -69.78 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | -1.64 | -2.15 | -4.34 | -5.45 |
| Cerenome, Inc. (CNSY)vs › | $10.81M | -4.43 | -27.97 | -98701.49 | -256134.32 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.66M | -0.47 | -0.74 | -0.71 | -0.50 |
| Lantern Pharma Inc. (LTRN)vs › | $12.06M | -1.62 | -966.25 | -483.82 | -322.89 |
| Lifeward Ltd. (LFWD)vs › | $10.49M | -16.82 | -28.56 | -28.65 | -34.30 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.26 |
| 2024-12-31 | -0.16 |
| 2023-12-31 | -0.29 |
| 2022-12-31 | -0.30 |
| 2021-12-31 | -0.22 |
| 2020-12-31 | -0.25 |
| 2019-12-31 | -0.11 |
